At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SDGR Schrodinger Inc.
Closed 11-13 16:00:00 EST
22.09
-0.16
-0.72%
盘后22.00
-0.09-0.41%
19:42 EST
High23.14
Low21.81
Vol1.35M
Open22.04
D1 Closing22.25
Amplitude5.98%
Mkt Cap1.61B
Tradable Cap1.37B
Total Shares72.80M
T/O30.18M
T/O Rate2.17%
Tradable Shares62.09M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Schrodinger price target raised to $28 from $27 at Goldman Sachs
Schrödinger Expects 2024 Software Revenue Growth Of 8%-13% Versus Prior Guidance Of 6%-13%, With Drug Discovery Revenue Guidance Of $20M-$30M Compared To $30M-$35M Expected Earlier
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.